[1]. N. Wit, E. Doremalen, D. Falzarano, and V. J. Munster, “SARS and MERS: recent insights into emerging coronaviruses,” Nat. Rev. Microbiol., vol. 14, pp. 523-534, 2016. [DOI:10.1038/nrmicro.2016.81]##
[2]. J. F. Chan, S. Yuan, K. H. Kok, K. K. To, H. Chu, J. Yang, et al., “A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster,” Lancet, 2020. [DOI:10.1016/s0140-6736(20) 30154-9]##
[3]. WHO. Novel coronavirus (2019-nCoV). Situation report 12. WHO; 2020.##
[4]. J. A. Otter, C. Donskey, S. Yezli, S. Douthwaite, S. D. Goldenberg, and D. J. Weber, “Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination,” J. Hosp. Infect., 2016. 92:235e50. [DOI: 10.1016/j.jhin.2015.08.027]##
[5]. S. F. Dowell, J. M. Simmerman, D. D. Erdman, J. S. Wu, A. Chaovavanich, M. Javadi, et al., “Severe acute respiratory syndrome coronavirus on hospital surfaces,” Clin Infect Dis., 2004. 39:652e7. [DOI:10.1086/422652]##
[6]. C. Geller, M. Varbanov, and R. E. Duval, “Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies,” Viruses 2012, 4:3044e68, 2012. [DOI: 10.3390/v4113044]##
[7]. G. Kampf, “Antiseptic stewardship: biocide resistance and clinical implications,” Cham: Springer International Publishing, 2018. [DOI: 10.1007/978-3-319-98785-9]##
[8]. Centers for Disease Control and Prevention, “Guidelines for Environmental Infection Control in Health-Care Facilities 2003,” updated 2019.##
[9]. National Health Commission, “Guideline of Diagnosis and Treatment for COVID-19 (7th Edition),”##
[10]. N. Van Doremalen, “Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1,” The new england journal of medicine, 2020. [DOI: 10.1101/2020.03.09.20033217]##
[11]. Y Jang, H. Wang, L. Chen, J. He, L. Chen, Y. Liu, et al., “Clinical data on hospital environmental hygiene monitoring and medical staff’s protection during the coronavirus disease 2019 outbreak,” 2020. [DOI: 10.1101/2020.02.25.20028043]##
[12]. K. Tran, K. Cimon, M. Severn, CL. Pessoa-Silva, and J. Conly, “Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review,” 7:e35797, PLoS one 2012. [DOI: 10.1371/journal.pone.0035797] [PMID]##
[13]. B. E. Young, S. W. X. Ong, S. Kalimuddin, J. G. Low, S. Y. Tan, J. Loh, et al., “Epidemiologic Features and Clinical Course of Patients Infected with SARS- CoV-2 in Singapore,” JAMA 2020. [DOI: 10.1001/jama.2020.3204] [PMID]##
[14]. S. W. X. Ong, Y. K. Tan, P. Y. Chia, T. H. Lee, O. T. Ng, M. S. Y. Wong, et al., “Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient,” JAMA 2020. [DOI: 10.1001/jama.2020.3227] [PMID]##
[15]. K. W. Luo and Z. Hai, “A COVID-19 patient travelled in buses infected 13 people,” Shiyong Yufang Yixue, vol. 3, 2020.##
[16]. P. Mecenas, R. T. da Rosa Moreira Bastos, A. C. Rosário Vallinoto, and D. Normando, “Effects of temperature and humidity on the spread of COVID-19: A systematic review,” Plos One, e0238339, vol. 15(9), 2020.##
[17]. S. Y. Ren, W. B. Wang, Y. G. Hao, H. R. Zhang, Z. C. Wang, Y. L. Chen, et al., “Stability and infectivity of coronaviruses in inanimate environments,” World J. Clin. Cases, vol. 8(8), pp. 1391-1399, 2020. [DOI:10.12998/wjcc.v 8.i8.1391]##
[18]. J. Sizun, M. W. Yu, P. J. Talbot,,“Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections,” J. Hosp. Infect., vol. 46, pp. 55-60, 2000. [DOI:10.1053/jhin.2000.0795] [PMID]##
[19]. M. Y. Lai, P. K. Cheng, and W. W. Lim, “Survival of severe acute respiratory syndrome coronavirus,” Clin Infect Dis., vol. 41, pp. 67-71, 2005. [DOI: 10.1086/433186] [PMID]##
[20]. M. K. Ijaz, A. H. Brunner, S. A. Sattar, R. C. Nair, and C. M. Johnson-Lussenburg, “Survival characteristics of airborne human coronavirus 229E,” J. Gen. Virol., vol. 66, 2743e8, 1985. [DOI: 10.1099/0022-1317-66-12-2743]##
[21]. H. F. Rabenau, G. Kampf, J. Cinatl, and HW, “Doerr. Efficacy of various disinfectants against SARS coronavirus,” J. Hosp. Infect., vol. 61, 107e11, 2005.##
[22]. V. Groupe, C. C. Engle, and P. E. Gaffney, “Virucidal activity of representative anti-infective agents against influenza A and vaccinia virus,” Appl. Microbiol., vol. 3, pp. 333-336, 1955.##
[23]. G. Kampf, M. Rudolf, J-C. Labadie, and S. P. Barrett, “Spectrum of antimicrobial activity and user acceptability of the hand disinfectant agent Sterillium Gel,” J. Hosp. Infect., vol. 52, pp. 141-147, 2002. [DOI:10.1053/jhin.2002.1281]##
[24]. C. H. Cunningham, “The effect of certain chemical agents on the virus of New castle disease of chicken,” Am. J. Vet. Res., vol. 9, pp. 195-197, 1948.##
[25]. M. A. Bucca, “The effect of various chemical agents on eastern equine encephalomyelitis virus,” J. Bacteriol., vol. 71, pp. 491-492, 1956.##
[26]. C. Payan, A. Pivert, G. Kampf, C. Ramon, J. Cottin, and C. Lemarie, “Assessment of new chemical disinfectants for HBV virucidal activity in a cell culture model,” J. Hosp. Infect., vol. 56, pp. 58-63, 2004. [DOI:10.1016/j.jhin.2003.12.031]##
[27]. L. S. Martin, J. S. Meoougal, and S. L. Loskoski, “Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy associated virus,” J. Infect. Dis., vol. 152, pp. 400-403, 1985. [DOI:10.1093/infdis/152.2.400]##
[28]. G. Kampf, D. Todt, S. Pfaender, and E. Steinmann, “Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents,” J. Hosp. Infect., 2020. [DOI:10.1016/ j.jhin.2020.01.022.]##
[29]. W. A. Rutala and D. J. Weber, “Healthcare Infection Control Practices Advisory Committee,” Guideline for disinfection and sterilization in healthcare facilities, Atlanta, GA: Centers for Disease Control and Prevention, 2008. [DOI: 10.1086/650197]##
[30]. A. Wood and D. Payne, “The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses,” J. Hosp. Infect., vol. 38, pp. 283-295, 1998. [DOI: 10.1016/S0195-6701(98)90077-9]##
[31]. F. G. Terpstra, A. E. Van Den Blink, L. M. Bos, A. G. Boots, F. H. Brinkhuis, E. Gijsen, et al., “Resistance of surface-dried virus to common disinfection procedures,” J. Hosp. Infect., vol. 66(4), pp. 332-338, 2007. [DOI: 10.1016/j.jhin.2007.05.005]
##
[32]. B. Bean, B. M. Moore, B. Sterner, L. R. Peterson, D. N. Gerding, and H. H. Balfour, “Survival of influenza viruses an environmental surface,” J. Infec. Dis., vol. 146, pp. 47-51, 1982. [DOI: 10.1093/infdis/146.1.47]##
[33]. S. A. Ansari, V. S. Springthorpe, S. A. Sattar, S. Rivard, and M. Rahman, “Potential rol
)
